During the past decade, CNS Healthcare - Orlando conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CNS Healthcare - Orlando" #1 collaborator was "Alzheimer's Association" with 1 trials as a collaborator and "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CNS Healthcare - Orlando" are "Alzheimer Disease" (1 trials), "Anxiety Generalized" (1 trials) and "Childhood-Onset Fluency Disorder" (1 trials). Many other conditions were trialed in "CNS Healthcare - Orlando" in a lesser frequency.

Most popular intervention types in "CNS Healthcare - Orlando" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AMX0035" (1 trials), "MM-120 (LSD D-Tartrate)" (1 trials) and "NOE-105" (1 trials). Other intervention names were less common.

The vast majority of trials in "CNS Healthcare - Orlando" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CNS Healthcare - Orlando". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CNS Healthcare - Orlando, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CNS Healthcare - Orlando, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".